Partnership & Collaborations
At Welab Barcelona, we believe that Partnership in biomedical innovation has the potential to bring innovative treatments to patients.
People is the real driving force of any endeavor. Ideas come from people, and research and development of new drugs is performed by people. True innovation will come from the vision, expertise, and talent of people. Innovation has many ingredients, but a single formula: COLLABORATION. Welab Barcelona is actively looking for partnership and collaborations with pharmaceutical industry, academia, research centers, CROs, and patient organizations. It is our strong conviction that this is the best way for dealing with the great challenges faced by medical research, and for providing new treatments for unmet therapeutic needs
Incubation of disruptive ideas with early innovation steps to move forward research programs, by providing:
- Go/no go frame
- Specialized R&D know-how, tools and pathways
Acceleration of existing and new research programs, providing specialized R&D experimental production to obtain "Pharma-quality assets" ready to be developed.
Assets shaped to fulfil the requirements of the pharmaceutical sector:
- Validation and therapeutic rationale
- Translatability
- Patents
- Regulatory and quality aspects
- Differentiation insights
- Definition of an optimised critical path for development
Clinical candidate pathway execution support:
- GLP pharmacokinetics
- Population PK/PD analysis
- Drafting of regulatory documents (EMA, FDA, AEMPS...): IB, IMPD, CTA, ERA, IND, NDA, ODD, PIP, CTD.)
- Interaction with Regulatory Authorities.